These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 19006606

  • 21. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V, Di Mario F, Scarpignato C.
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S, Birk J.
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 25 Years of Proton Pump Inhibitors: A Comprehensive Review.
    Strand DS, Kim D, Peura DA.
    Gut Liver; 2017 Jan 15; 11(1):27-37. PubMed ID: 27840364
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
    Sanders SW.
    Clin Ther; 1996 Jan 15; 18(1):2-34; discussion 1. PubMed ID: 8851451
    [Abstract] [Full Text] [Related]

  • 29. Pharmacologic properties of proton pump inhibitors.
    Welage LS.
    Pharmacotherapy; 2003 Oct 15; 23(10 Pt 2):74S-80S. PubMed ID: 14587961
    [Abstract] [Full Text] [Related]

  • 30. Lansoprazole: a proton pump inhibitor.
    Garnett WR.
    Ann Pharmacother; 1996 Dec 15; 30(12):1425-36. PubMed ID: 8968456
    [Abstract] [Full Text] [Related]

  • 31. Treatment advances in acid secretory disorders: the promise of rapid symptom relief with disease resolution.
    Earnest DL, Robinson M.
    Am J Gastroenterol; 1999 Nov 15; 94(11 Suppl):S17-24. PubMed ID: 10565605
    [Abstract] [Full Text] [Related]

  • 32. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS, Shah AK, Bariwal J, Shelke SM, Kale AP, Jagtap JR, Bhosale AV.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1181-205. PubMed ID: 17150362
    [Abstract] [Full Text] [Related]

  • 33. Gastric H,K-ATPase as a drug target.
    Shin JM, Sachs G.
    Dig Dis Sci; 2006 May 01; 51(5):823-33. PubMed ID: 16645899
    [No Abstract] [Full Text] [Related]

  • 34. Suppression of acid secretion in peptic ulcer disease.
    Feldman M.
    J Clin Gastroenterol; 1995 May 01; 20 Suppl 1():S1-6. PubMed ID: 7673607
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J, Louis E, Persy V, Urbain D.
    Acta Gastroenterol Belg; 2013 Dec 01; 76(4):393-402. PubMed ID: 24592542
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Acid suppression therapy: where do we go from here?
    Scarpignato C, Pelosini I, Di Mario F.
    Dig Dis; 2006 Dec 01; 24(1-2):11-46. PubMed ID: 16699262
    [Abstract] [Full Text] [Related]

  • 39. History of acid suppression: focus on the hospital setting.
    Garnett WR.
    Pharmacotherapy; 2003 Oct 01; 23(10 Pt 2):56S-60S. PubMed ID: 14587958
    [Abstract] [Full Text] [Related]

  • 40. Molecular mechanisms in therapy of acid-related diseases.
    Shin JM, Vagin O, Munson K, Kidd M, Modlin IM, Sachs G.
    Cell Mol Life Sci; 2008 Jan 01; 65(2):264-81. PubMed ID: 17928953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.